Citation Tools

Download PDFPDF
Extended report
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Download to a citation manager

Cite this article as:
Leirisalo-Repo M, Kautiainen H, Laasonen L, et al
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)